Viwit Pharmaceutical Co., Ltd – FDA 483, Apr 8, 2025
Viwit Pharmaceutical Co., Ltd, a manufacturer of sterile drugs and contract laboratory in Zaozhuang, China, was inspected and cited for significant deficiencies across its quality, production, and laboratory systems. Observations included inadequate documentation of production procedures, failure to thoroughly investigate out-of-specification results, and critical deficiencies in aseptic processing and microbiological contamination prevention. These issues indicate a lack of control over sterile drug manufacturing processes.
ID · 06c025a7-d591-4b1a-96e3-e3cdedfcb6b3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.